[Baltimore Sun] McDaniel students to compete for $5,000 prize at entrepreneurship challenge
One McDaniel student will win $5,000 Thursday night, at the college’s annual Innovation and Entrepreneurship Challenge. The prize money is awarded for creating an exceptional...
[Baltimore Sun] Howard County Executive Calvin Ball unveils $2.4 billion operating budget
Howard County Executive Calvin Ball presented the county’s proposed $2.4 billion operating budget for fiscal 2025 on Tuesday. Most of the budget, $1.14 billion, is...
[Fox Business] Eli Lilly’s weight loss drug reduces sleep apnea, study shows
Eli Lilly’s weight loss-related drug Zepbound could potentially be used to reduce the severity of sleep apnea in adults with obesity, according to a recent study.
Results of a phase three clinical trial, published Wednesday, showed that injections of the drug, either 10 mg or 15 mg, “significantly reduced the apnea-hypopnea index (AHI) compared to placebo.”
Specifically, Lilly noted that tirzepatide, the active ingredient in Zepbound, reduced sleep apnea severity by up to nearly two-thirds in adults that have both obstructive sleep apnea (OSA), a sleep-related breathing disorder, and obesity.
OSA is caused by a complete or partial collapse of the upper airway during sleep. Its effects can lead to “apnea or hypopnea and a potential decrease in oxygen saturation and/or waking from sleep,” according to Lilly.
The disorder impacts 80 million adults in the U.S. and can result in “serious cardiometabolic complications, contributing to hypertension, coronary heart disease, stroke, heart failure, atrial fibrillation and type 2 diabetes,” Lilly said.
“Addressing this unmet need head-on is critical, and while there are pharmaceutical treatments for the excessive sleepiness associated with OSA, tirzepatide has the potential to be the first pharmaceutical treatment for the underlying disease,” Dr. Jeff Emmick, senior vice president of product development at Lilly, said in a statement.
Based on these results, Lilly said it plans to submit this data for global regulatory review.
WEGOVY, THE WEIGHT-LOSS MEDICATION, GETS FDA APPROVAL FOR USE AS HEART DISEASE PREVENTION DRUG
NOVO NORDISK CEO SAYS FOOD EXECS ARE ‘SCARED’ OF WEIGHT-LOSS DRUG THREAT
The adults who were evaluated were not on positive airway pressure (PAP) therapy, which uses a machine to pump air under pressure into the lungs, for 52 weeks during the trial.
Currently, tirzepatide is approved for chronic weight management and sold under the brand name Zepbound. It’s also approved for treatment of Type 2 diabetes and sold under the brand name Mounjaro.
[WBALTV] Biden promises to keep US Steel a ‘totally American company’ amid review of Japanese takeover plan
Biden said during a visit to the headquarters of the United Steelworkers union that U.S. Steel “has been an iconic American company for more than...
[WBALTV] Comptroller concerned for services in 2025 budget plan
Baltimore City's top finance official shared concerns Wednesday about next year's budget proposal and the years ahead. Read More
[NewYorkPost] Score big with BetMGM Bonus Code NYPNEWS1600: Get 20% deposit match
BetMGM Sportsbook is showcasing two excellent sign-up offers for new customers in most sports betting states. Read More
[NewYorkPost] Caesars Sportsbook promo code: $1K insurance or 10 profit boosts all week
New bettors looking for a welcome promo can find three different Caesars Sportsbook promo code offers depending on the sports betting state. Read More
[NewYorkPost] The race to replace John Sterling on Yankees radio is wide open
There appear to be at least four candidates to become John Sterling's permanent replacement as the Yankees' radio play-by-play voice. Read More
[NewYorkPost] Seven NBA Play-In sports betting bonuses & promos you can use for NBA, any sport
Check out the best betting promos and sports betting sites for the NBA Play-In Tournament, or any other sport. Read More
[NewYorkPost] Unlock $150 or $1,000 Safety Net for any game with bet365 Bonus Code NYPNEWS
Get your pick of either a $150 bet and get, or a $1K bet insurance promotion when you sign up for an account with the...